NEU neuren pharmaceuticals limited

Ann: Phase 3 trial of trofinetide in Rett syndrome commences, page-6

  1. 3,997 Posts.
    lightbulb Created with Sketch. 687
    The weird thing is that now that the phase 3 trial has started, perhaps NEU should not sell most of their ROW asset...the trial only takes 12 weeks, and recruitment might be reasonably speedy, considering the parents will know about the trial and be keen to participate.

    and NEU doesn’t really need the money ... it is a shame there doesn’t appear to be a small milestone payment for commencing phase 3.

    It was a different story 12 months ago the heavily back-ended Acadia deal was announced, and the phase 3 trial was just a far away “gunna-do-this-one-day”promise.

    now the trial has started, I think Neuren should just wait it out a bit longer, if they are pretty certain the trial will succeed.

    maybe a compromise could be to do a Japan deal or some other small one country-only deal.
    Last edited by hotcongo: 31/10/19
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.20
Change
0.890(6.69%)
Mkt cap ! $1.761B
Open High Low Value Volume
$13.50 $14.26 $12.96 $9.111M 655.8K

Buyers (Bids)

No. Vol. Price($)
1 2000 $14.17
 

Sellers (Offers)

Price($) Vol. No.
$14.23 3278 1
View Market Depth
Last trade - 16.15pm 27/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.